Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperone protein, has broad oncogenic properties.

Zella D, Curreli S, Benedetti F, Krishnan S, Cocchi F, Latinovic OS, Denaro F, Romerio F, Djavani M, Charurat ME, Bryant JL, Tettelin H, Gallo RC.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E12005-E12014. doi: 10.1073/pnas.1815660115. Epub 2018 Dec 3. Erratum in: Proc Natl Acad Sci U S A. 2019 Jan 7;:.

2.

Mycoplasma hominis and Mycoplasma genitalium in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection.

Adebamowo SN, Ma B, Zella D, Famooto A, Ravel J, Adebamowo C; ACCME Research Group.

Front Public Health. 2017 Jun 26;5:140. doi: 10.3389/fpubh.2017.00140. eCollection 2017.

3.

Anti-inflammatory effects of H2S during acute bacterial infection: a review.

Benedetti F, Curreli S, Krishnan S, Davinelli S, Cocchi F, Scapagnini G, Gallo RC, Zella D.

J Transl Med. 2017 May 10;15(1):100. doi: 10.1186/s12967-017-1206-8. Review.

4.

Epigenetic nutraceutical diets in Alzheimer's disease.

Davinelli S, Calabrese V, Zella D, Scapagnini G.

J Nutr Health Aging. 2014 Nov;18(9):800-5. doi: 10.1007/s12603-014-0520-6. Review.

PMID:
25389957
5.

Altered expression pattern of Nrf2/HO-1 axis during accelerated-senescence in HIV-1 transgenic rat.

Davinelli S, Scapagnini G, Denaro F, Calabrese V, Benedetti F, Krishnan S, Curreli S, Bryant J, Zella D.

Biogerontology. 2014;15(5):449-61. doi: 10.1007/s10522-014-9511-6. Epub 2014 Jul 16.

PMID:
25027760
6.

Sulfur compounds block MCP-1 production by Mycoplasma fermentans-infected macrophages through NF-κB inhibition.

Benedetti F, Davinelli S, Krishnan S, Gallo RC, Scapagnini G, Zella D, Curreli S.

J Transl Med. 2014 May 24;12:145. doi: 10.1186/1479-5876-12-145.

7.

B cell lymphoma in HIV transgenic mice.

Curreli S, Krishnan S, Reitz M, Lunardi-Iskandar Y, Lafferty MK, Garzino-Demo A, Zella D, Gallo RC, Bryant J.

Retrovirology. 2013 Aug 28;10:92. doi: 10.1186/1742-4690-10-92.

8.

Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells.

Davinelli S, Sapere N, Visentin M, Zella D, Scapagnini G.

Immun Ageing. 2013 Jul 11;10(1):28. doi: 10.1186/1742-4933-10-28.

9.

MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies.

Tisato V, Norcio A, Voltan R, Celeghini C, Zella D, Secchiero P.

Curr Med Chem. 2013;20(17):2226-36. Review.

PMID:
23458617
10.

Synergistic effect of L-Carnosine and EGCG in the prevention of physiological brain aging.

Davinelli S, Di Marco R, Bracale R, Quattrone A, Zella D, Scapagnini G.

Curr Pharm Des. 2013;19(15):2722-7.

PMID:
23092324
11.

Pleiotropic protective effects of phytochemicals in Alzheimer's disease.

Davinelli S, Sapere N, Zella D, Bracale R, Intrieri M, Scapagnini G.

Oxid Med Cell Longev. 2012;2012:386527. doi: 10.1155/2012/386527. Epub 2012 May 28. Review.

12.

The "Alzheimer's disease signature": potential perspectives for novel biomarkers.

Davinelli S, Intrieri M, Russo C, Di Costanzo A, Zella D, Bosco P, Scapagnini G.

Immun Ageing. 2011 Sep 20;8:7. doi: 10.1186/1742-4933-8-7.

13.

Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.

Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G.

Mol Neurobiol. 2011 Oct;44(2):192-201. doi: 10.1007/s12035-011-8181-5. Epub 2011 Apr 19. Review. Erratum in: Mol Neurobiol. 2011 Oct;44(2):202. Sonya, Vasto [corrected to Vasto, Sonya]; Nader, Abraham G [corrected to Abraham, Nader G]; Calogero, Caruso [corrected to Caruso, Calogero].

14.

Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo.

Candido R, Toffoli B, Corallini F, Bernardi S, Zella D, Voltan R, Grill V, Celeghini C, Fabris B.

J Vasc Res. 2010;47(3):252-61. doi: 10.1159/000257339. Epub 2009 Nov 11.

15.

Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.

Pazgier M, Liu M, Zou G, Yuan W, Li C, Li C, Li J, Monbo J, Zella D, Tarasov SG, Lu W.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4665-70. doi: 10.1073/pnas.0900947106. Epub 2009 Mar 2.

16.

Turning a scorpion toxin into an antitumor miniprotein.

Li C, Liu M, Monbo J, Zou G, Li C, Yuan W, Zella D, Lu WY, Lu W.

J Am Chem Soc. 2008 Oct 15;130(41):13546-8. doi: 10.1021/ja8042036. Epub 2008 Sep 18.

17.

Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats.

Mazzucchelli R, Amadio M, Curreli S, Denaro F, Bemis K, Reid W, Bryant J, Riva A, Galli M, Zella D.

Mol Immunol. 2004 Aug;41(10):979-84.

PMID:
15302160
18.
19.

TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.

Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, Zella D, Zauli G.

Circulation. 2003 May 6;107(17):2250-6. Epub 2003 Mar 31.

PMID:
12668516
20.

Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.

Heredia A, Davis C, Amoroso A, Dominique JK, Le N, Klingebiel E, Reardon E, Zella D, Redfield RR.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4179-84. Epub 2003 Mar 18.

21.

IFN-alpha2b increases interleukin-10 expression in primary activated human CD8+ T cells.

Curreli S, Romerio F, Secchiero P, Zella D.

J Interferon Cytokine Res. 2002 Dec;22(12):1167-73.

PMID:
12581488
22.

MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.

Romerio F, Zella D.

FASEB J. 2002 Oct;16(12):1680-2. Epub 2002 Aug 21.

PMID:
12206994
23.

Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells.

Secchiero P, Mirandola P, Zella D, Celeghini C, Gonelli A, Vitale M, Capitani S, Zauli G.

Blood. 2001 Oct 15;98(8):2474-81.

24.

Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase.

Curreli S, Romerio F, Mirandola P, Barion P, Bemis K, Zella D.

J Interferon Cytokine Res. 2001 Jun;21(6):431-7.

PMID:
11440641
25.

Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.

Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, Zauli G.

J Immunol. 2000 Apr 15;164(8):4018-24.

26.

Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication.

Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, Zauli G.

Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14620-5.

27.
28.

Stromal derived factor-1alpha induces apoptosis in activated primary CD4+ T cells.

Colamussi ML, Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Zauli G.

AIDS. 2000 Apr 14;14(6):748-50. No abstract available.

PMID:
10807201
29.

IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells.

Zella D, Romerio F, Curreli S, Secchiero P, Cicala C, Zagury D, Gallo RC.

J Immunol. 2000 Mar 1;164(5):2296-302.

30.

Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells.

Zella D, Barabitskaja O, Casareto L, Romerio F, Secchiero P, Reitz MS Jr, Gallo RC, Weichold FF.

J Immunol. 1999 Sep 15;163(6):3169-75.

31.

Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells.

Secchiero P, Zella D, Capitani S, Gallo RC, Zauli G.

J Immunol. 1999 Feb 15;162(4):2427-31.

32.

Quantitative PCR for HIV-1 Proviral DNA.

Zella D, Secchiero P.

Methods Mol Med. 1999;17:119-24. doi: 10.1385/0-89603-369-4:119.

PMID:
21380663
33.

Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7.

Secchiero P, Zella D, Barabitskaja O, Reitz MS, Capitani S, Gallo RC, Zauli G.

Blood. 1998 Dec 15;92(12):4521-8.

34.

A novel sensitive assay to define immune status using short-term peripheral blood derived cell culture and dual-color flow cytometry.

Zella D, Riva A, Weichold FF, Reitz MS Jr, Gerna G.

Immunol Lett. 1998 May;62(1):45-9.

PMID:
9672147
35.

Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells.

Zella D, Barabitskaja O, Burns JM, Romerio F, Dunn DE, Revello MG, Gerna G, Reitz MS Jr, Gallo RC, Weichold FF.

Blood. 1998 Jun 15;91(12):4444-50.

36.

Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures.

Weichold FF, Zella D, Barabitskaja O, Maciejewski JP, Dunn DE, Sloand EM, Young NS.

Blood. 1998 Feb 1;91(3):907-15.

37.

Use of reverse-transcription polymerase chain reaction for detection of rubella virus RNA in cell cultures inoculated with clinical samples.

Revello MG, Sarasini A, Baldanti F, Percivalle E, Zella D, Gerna G.

New Microbiol. 1997 Jul;20(3):197-206.

PMID:
9258938
39.

Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction.

Revello MG, Baldanti F, Sarasini A, Zella D, Zavattoni M, Gerna G.

Clin Diagn Virol. 1997 Feb;7(3):183-91.

PMID:
9126688
40.

Diagnosis of human cytomegalovirus infections in the immunocompromised host.

Gerna G, Zavattoni M, Percivalle E, Zella D, Torsellini M, Revello MG.

Clin Diagn Virol. 1996 May;5(2-3):181-6.

PMID:
15566876
41.

Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes.

Crowley RW, Secchiero P, Zella D, Cara A, Gallo RC, Lusso P.

J Immunol. 1996 Mar 1;156(5):2004-8.

PMID:
8596056
42.

Quantitative PCR for human herpesviruses 6 and 7.

Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P.

J Clin Microbiol. 1995 Aug;33(8):2124-30.

43.

Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.

Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, Reitz MS Jr, Gallo RC.

Nat Med. 1995 Jul;1(7):667-73.

PMID:
7585149
44.

Utilization of a DNA enzyme immunoassay for the detection of proviral DNA of human immunodeficiency virus type 1 by polymerase chain reaction.

Zella D, Cavicchini A, Cattaneo E, Cimarelli A, Bertazzoni U.

Clin Diagn Virol. 1995 Feb;3(2):155-64.

PMID:
15566797
45.

Detection of human cytomegalovirus DNA: how, when and where?

Gerna G, Baldanti F, Zella D, Furione M.

Scand J Infect Dis Suppl. 1995;99:11-5. Review.

PMID:
8668932
47.

Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction.

Zipeto D, Baldanti F, Zella D, Furione M, Cavicchini A, Milanesi G, Gerna G.

J Virol Methods. 1993 Sep;44(1):45-55.

PMID:
8227278
48.

Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates.

Zella D, Cavicchini A, Salemi M, Casoli C, Lori F, Achilli G, Cattaneo E, Landini V, Bertazzoni U.

J Gen Virol. 1993 Mar;74 ( Pt 3):437-44.

PMID:
8445366
49.

HTLV-II infection in Italian drug abusers.

Zella D, Mori L, Sala M, Ferrante P, Casoli C, Magnani G, Achilli G, Cattaneo E, Lori F, Bertazzoni U.

Lancet. 1990 Sep 1;336(8714):575-6. No abstract available.

PMID:
1975077
50.

Enzymatically active forms of reverse transcriptase of the human immunodeficiency virus.

Lori F, Scovassi AI, Zella D, Achilli G, Cattaneo E, Casoli C, Bertazzoni U.

AIDS Res Hum Retroviruses. 1988 Oct;4(5):393-8.

PMID:
2461725

Supplemental Content

Support Center